Multidrug Resistance in Prostate Cancer

Publisher： Karger

E-ISSN： 2296-5262|26|2|175-181

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.2, 2003-05, pp. : 175-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanomedicine against multidrug resistance in cancer treatment

By Gao Jie   Feng Si-Shen   Guo Yajun  

Nanomedicine, Vol. 7, Iss. 4, 2012-04 ,pp. : 465-468

Future Medicine

Access to resources Recommend Favorite

In prostate cancer, low adiponectin levels are not associated with insulin resistance

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 6, 2015-06 ,pp. : 572-578

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABCG2-Meditated Multidrug Resistance and Tumor-Initiating Capacity of Side Population Cells from Colon Cancer

By  

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-10 ,pp. : 666-672

Karger

Access to resources Recommend Favorite

Enhancement of ovarian cancer chemotherapy by delivery of multidrug‐resistance gene small interfering RNA using tumor targeting Salmonella

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 4, 2015-04 ,pp. : 615-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanocarriers for overcoming multidrug resistance in cancers

By Banerjee R  

Nanomedicine, Vol. 1, Iss. 4, 2006-12 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite